BACKGROUND AND PURPOSE: It is unclear whether the costs and risks of mechanical
therapies make them cost-effective. We examined whether interventions such as mechanical …

Background: The beneficial effects of endovascular treatment with new-generation
mechanical thrombectomy devices compared with intravenous thrombolysis alone to treat …

Object Mechanical thrombectomy is increasingly being used for the treatment of large-vessel
ischemic stroke in patients who arrive outside of the 3-hour tissue plasminogen activator …

Background In Ontario, current treatment for eligible patients who have an acute ischemic
stroke is intravenous thrombolysis (IVT). However, there are some limitations and …

Background Acute ischemic stroke (AIS) is a leading cause of morbidity and mortality.
However, precisely defining the optimal treatment for individual patients early after AIS onset …

Background: Acute ischemic stroke is a leading cause of serious disability and death
worldwide. Individual randomized trials have shown possible benefits of mechanical …

As healthcare delivery in the USA transforms into a model that at its core requires value-
based considerations, ischemic stroke is confronted by intersecting forces. Modern …

Background Recent clinical trials have demonstrated the efficacy of mechanical
thrombectomy in acute ischemic stroke. Aims To determine the cost-effectiveness, value of …

Background and Purpose—Mechanical thrombectomy has the potential to improve
recanalization rates and outcomes for patients with ischemic stroke, but potential gains …

Introduction Recent studies showed improved patient outcomes with endovascular treatment
of acute stroke compared to medical care, including IV rtPA, alone. Seven trials have …